What is Medibloc (MED)?
MediBloc’s healthcare information platform is a personal data ecosystem for patients, providers and researchers, built on blockchain technology. Our mission is to streamline medicine for patients, providers and researchers by redistributing value behind personal healthcare data ownership.Through MediBloc, you can effectively own your medical data, providers can remove redundancies to provide better care, and your valuable data can help researchers push the advancement of medicine faster than ever.
Where can you buy Medibloc?
Medibloc (MED) is traded on a wide range of centralized and decentralized exchanges. The most liquid markets for MED sit on tier-1 venues - the sort of exchanges where institutional desks and professional market makers rebalance continuously - which is what keeps the spread tight and the last price tied closely to fair value.
You can open the Markets section above to see the live list of exchanges quoting MED, sorted by 24-hour volume. Each row links to the venue's trade page so you can go directly from research to execution without copying the ticker around by hand.
What is the daily trading volume of Medibloc (MED)?
The reported 24-hour trading volume of Medibloc is $246.40K. Volume is a live reading of how much MED changed hands across all tracked exchanges in the past day and tends to rise during periods of price discovery and fall during consolidation.
For traders, the ratio between volume and market cap is often more informative than either number on its own: a high vol-to-mcap ratio indicates liquid, actively traded supply, while a low ratio suggests that most holders are sitting on the asset.
What is the highest and lowest price for Medibloc (MED)?
Medibloc reached an all-time high of $0.3519 on April 1, 2021, and an all-time low of $0.001174 on August 17, 2026. It is currently trading -99.58% from its peak and +24.43% from its bottom.
The distance from ATH is a useful gauge of recovery potential during a bear market and of stretched positioning during a bull market. Combined with the all-time-low figure it provides a quick statistical frame for thinking about where MED sits in its long-run price range.
